These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22888151)
1. Neuroenhancers, addiction and research ethics. Shaw DM J Med Ethics; 2012 Oct; 38(10):605-8. PubMed ID: 22888151 [TBL] [Abstract][Full Text] [Related]
2. True and false concerns about neuroenhancement: a response to 'Neuroenhancers, addiction and research ethics', by D M Shaw. Heinz A; Kipke R; Müller S; Wiesing U J Med Ethics; 2014 Apr; 40(4):286-7. PubMed ID: 23468510 [TBL] [Abstract][Full Text] [Related]
3. Cognitive neuroenhancement: false assumptions in the ethical debate. Heinz A; Kipke R; Heimann H; Wiesing U J Med Ethics; 2012 Jun; 38(6):372-5. PubMed ID: 22228818 [TBL] [Abstract][Full Text] [Related]
4. [Options, limits and ethics of pharmacological neuroenhancement]. Normann C; Boldt J; Maio G; Berger M Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745 [TBL] [Abstract][Full Text] [Related]
5. Brain gain: the underground world of neuroenhancing drugs. Talbot M New Yorker; 2009 Apr; ():32-43. PubMed ID: 19399986 [No Abstract] [Full Text] [Related]
6. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people. Boot BP; Partridge B; Hall W Neurocase; 2012 Jun; 18(3):181-4. PubMed ID: 22007842 [TBL] [Abstract][Full Text] [Related]
7. The action of enhancers can lead to addiction. Volkow ND; Swanson JM Nature; 2008 Jan; 451(7178):520. PubMed ID: 18235477 [No Abstract] [Full Text] [Related]
8. Stimulant medications: how to minimize their reinforcing effects? Volkow ND Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852 [No Abstract] [Full Text] [Related]
9. Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study. Hildt E; Lieb K; Bagusat C; Franke AG Biomed Res Int; 2015; 2015():621075. PubMed ID: 26064931 [TBL] [Abstract][Full Text] [Related]
10. Ethical issues in the use of cognitive enhancement. Darby R Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(2):16-22. PubMed ID: 20455376 [No Abstract] [Full Text] [Related]
11. Cognitive and Performance Enhancing Medication Use to Improve Performance in Poker. Caballero J; Ownby RL; Rey JA; Clauson KA J Gambl Stud; 2016 Sep; 32(3):835-45. PubMed ID: 26450125 [TBL] [Abstract][Full Text] [Related]
13. Reining in the pharmacological enhancement train: we should remain vigilant about regulatory standards for prescribing controlled substances. Drabiak-Syed K J Law Med Ethics; 2011; 39(2):272-9. PubMed ID: 21561522 [TBL] [Abstract][Full Text] [Related]
15. Accelerating human evolution. Harris ED Pharos Alpha Omega Alpha Honor Med Soc; 2009; 72(3):1. PubMed ID: 19722297 [No Abstract] [Full Text] [Related]
16. The ethics of research on enhancement interventions. Lev O; Miller FG; Emanuel EJ Kennedy Inst Ethics J; 2010 Jun; 20(2):101-13. PubMed ID: 20653248 [TBL] [Abstract][Full Text] [Related]
17. Neuroenhancement: status quo and perspectives. Normann C; Berger M Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():110-4. PubMed ID: 18985306 [TBL] [Abstract][Full Text] [Related]
18. [Screening, by clinical observation, signs and symptoms of addiction to the use of general practice]. Bertolini M Rev Med Suisse; 2011 Sep; 7(309):1789-90, 1792-3. PubMed ID: 22016932 [TBL] [Abstract][Full Text] [Related]
19. American culture and neuro-cognitive enhancing drugs. Flaskerud JH Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164 [No Abstract] [Full Text] [Related]
20. Neurobehavioral Sequelae of Psychostimulant Abuse. Djamshidian A Int Rev Neurobiol; 2015; 120():161-77. PubMed ID: 26070757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]